DCTPep06796 |
SEQ ID NO: 513 of Patent CN110785183A |
KLVELEHTL |
9 |
Synthetic |
DCTPep06797 |
SEQ ID NO: 514 of Patent CN110785183A |
VQLDSIEDLEV |
11 |
Synthetic |
DCTPep06798 |
SEQ ID NO: 515 of Patent CN110785183A |
KIFEMLEGV |
9 |
Synthetic |
DCTPep06799 |
SEQ ID NO: 516 of Patent CN110785183A |
YTFSGDVQL |
9 |
Synthetic |
DCTPep06800 |
SEQ ID NO: 517 of Patent CN110785183A |
TLYNPERTITV |
11 |
Synthetic |
DCTPep06801 |
SEQ ID NO: 518 of Patent CN110785183A |
GLLEDERALQL |
11 |
Synthetic |
DCTPep06802 |
SEQ ID NO: 519 of Patent CN110785183A |
KIQEILTQV |
9 |
Synthetic |
DCTPep06803 |
SEQ ID NO: 520 of Patent CN110785183A |
KIQEMQHFL |
9 |
Synthetic |
DCTPep06804 |
SEQ ID NO: 521 of Patent CN110785183A |
FVYGEPREL |
9 |
Synthetic |
DCTPep06805 |
SEQ ID NO: 522 of Patent CN110785183A |
TLDEKVAEL |
9 |
Synthetic |
DCTPep06806 |
SEQ ID NO: 523 of Patent CN110785183A |
HLIAEIHTA |
9 |
Synthetic |
DCTPep06807 |
SEQ ID NO: 524 of Patent CN110785183A |
KVWSDVTPL |
9 |
Synthetic |
DCTPep06808 |
SEQ ID NO: 525 of Patent CN110785183A |
RLDDLKMTV |
9 |
Synthetic |
DCTPep06809 |
SEQ ID NO: 526 of Patent CN110785183A |
VLSPFILTL |
9 |
Synthetic |
DCTPep06810 |
SEQ ID NO: 527 of Patent CN110785183A |
LLDSVSRL |
8 |
Synthetic |
DCTPep06811 |
SEQ ID NO: 528 of Patent CN110785183A |
RLLDSVSRL |
9 |
Synthetic |
DCTPep06812 |
SEQ ID NO: 529 of Patent CN110785183A |
HPSAHDVIL |
9 |
Synthetic |
DCTPep06813 |
SEQ ID NO: 530 of Patent CN110785183A |
APAAWLRSAA |
10 |
Synthetic |
DCTPep06830 |
CD9-BP |
RSHRLRLH |
8 |
EWI-2 protein |
DCTPep06862 |
#2(D33-N52) |
RRRRRRRRGGDRDYKKFWAGLQGLTIYFYN |
30 |
Synthetic (STAP-2 PH domain–derived peptide) |
DCTPep06863 |
#6(M108-L127) |
RRRRRRRRGGMWKGFILTVVELRVPTDLTL |
30 |
Synthetic (STAP-2 PH domain–derived peptide) |
DCTPep06864 |
2A(F39-Q58) |
RRRRRRRRGGFWAGLQGLTIYFYNSNRDFQ |
30 |
Synthetic (STAP-2 PH domain–derived peptide) |
DCTPep06865 |
2C(Q44-Q58) |
RRRRRRRRGGQGLTIYFYNSNRDFQ |
25 |
Synthetic (STAP-2 PH domain–derived peptide) |
DCTPep06866 |
2D(Q44-R55) |
RRRRRRRRGGQGLTIYFYNSNR |
22 |
Synthetic (STAP-2 PH domain–derived peptide) |
DCTPep06867 |
2D2(Q44-Y51) |
RRRRRRRRGGQGLTIYFY |
18 |
Synthetic (STAP-2 PH domain–derived peptide) |
DCTPep06868 |
2D3(G45-N52) |
RRRRRRRRGGGLTIYFYN |
18 |
Synthetic (STAP-2 PH domain–derived peptide) |
DCTPep06869 |
2D5(G45-Y51) |
RRRRRRRRGGGLTIYFY |
17 |
Synthetic (STAP-2 PH domain–derived peptide) |
DCTPep06870 |
6E(V116-M135) |
RRRRRRRRGGVVELRVPTDLTLLPGHLYMM |
30 |
Synthetic (STAP-2 PH domain–derived peptide) |
DCTPep06871 |
6F (I113-P122) |
RRRRRRRRGGILTVVELRVP |
20 |
Synthetic (STAP-2 PH domain–derived peptide) |
DCTPep06872 |
|
IWDTIEK |
7 |
Snake venom of N. kaouthia |